Cargando…

Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?

In recent decades, technical advances in surgery and radiotherapy, as well as breakthroughs in the knowledge on cancer biology, have helped to substantially improve the standard of cancer care with respect to overall response rates, progression-free survival, and the quality of life of cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wirsdörfer, Florian, de Leve, Simone, Jendrossek, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337556/ https://www.ncbi.nlm.nih.gov/pubmed/30577587 http://dx.doi.org/10.3390/ijms20010024

Ejemplares similares

Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
por: de Leve, Simone, et al.
Publicado: (2019)

Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578
por: de Leve, Simone, et al.
Publicado: (2019)

The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
por: de Leve, Simone, et al.
Publicado: (2019)

The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
por: Wirsdörfer, Florian, et al.
Publicado: (2016)

Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity
por: Meyer, Alina V., et al.
Publicado: (2020)

Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
por: Wirsdörfer, Florian, et al.
Publicado: (2017)

Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells
por: Wirsdörfer, Florian, et al.
Publicado: (2014)

Can we expect an increased suicide rate due to Covid-19?
por: Devitt, Patrick
Publicado: (2020)

Oncometabolites and the response to radiotherapy
por: Xiang, Kexu, et al.
Publicado: (2020)

Fecal Microbiota Transplant in Immunotherapy-Resistant Melanoma: What Can We Expect in the Near Future?
por: Ferreira, André, et al.
Publicado: (2022)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Bunch intensity limitations; 1, what do we expect?
por: Hofmann, A
Publicado: (1995)

Can we determine whether physical limitations are more prevalent in the US than in countries with comparable life expectancy?
por: Glei, Dana A., et al.
Publicado: (2017)

Defying Expectations: Can We Identify Neighbourhoods with “Other Than Expected” Developmental Outcomes?
por: Duku, Eric, et al.
Publicado: (2022)

Emerging virus diseases: can we ever expect the unexpected?
por: Howard, Colin R, et al.
Publicado: (2012)

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

Unusual malar rash with ulceration: What can we expect?
por: Chaima, Kouki, et al.
Publicado: (2023)

Autogenic Training in Mental Disorders: What Can We Expect?
por: Breznoscakova, Dagmar, et al.
Publicado: (2023)

CD47 restricts antiviral function of alveolar macrophages during influenza virus infection
por: Wenzek, Christina, et al.
Publicado: (2022)

Replications in Comparative Cognition: What Should We Expect and How Can We Improve?
por: Farrar, Benjamin G., et al.
Publicado: (2020)

Ketamine plus Alcohol: What We Know and What We Can Expect about This
por: Kobayashi, Natalia Harumi Correa, et al.
Publicado: (2022)

Complex congenital scoliosis: brace treatment. What can we expect?
por: Kaced, Houria, et al.
Publicado: (2010)

Can We Expect Results-Based Financing to Improve Quality of Care?
Publicado: (2017)

Modelling Covid-19 under uncertainty: what can we expect?
por: Wang, Meimei, et al.
Publicado: (2020)

Lung cancer in the era of COVID-19: what can we expect?
por: Araujo-Filho, Jose de Arimateia Batista, et al.
Publicado: (2020)

The male disadvantage in life expectancy: can we close the gender gap?
por: Hossin, Muhammad Zakir
Publicado: (2021)

GERD after Bariatric Surgery. Can We Expect Endoscopic Findings?
por: Vilallonga, Ramon, et al.
Publicado: (2021)

Apoptosis induction and tumor cell repopulation: The yin and yang of radiotherapy
por: Lauber, Kirsten, et al.
Publicado: (2011)

Surviving breast cancer: can women expect to 'get back to normal'?
por: Hopwood, P
Publicado: (2008)

Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
por: Ritter, Violetta, et al.
Publicado: (2021)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
por: Son, Christine, et al.
Publicado: (2023)

Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
por: Ritter, Violetta, et al.
Publicado: (2022)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
por: Martin-Romano, Patricia, et al.
Publicado: (2021)

The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?
por: Courtet, P, et al.
Publicado: (2011)

Real World Evidence: Can We Really Expect It to Have Much Influence?
por: Evans, Keith
Publicado: (2019)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

Intensity: limitations and expectations
por: Hofmann, A
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_k9bibc7f0q1o963mmc56adqqai